These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24890202)

  • 21. Complications and adverse reactions with the use of botulinum toxin.
    Klein AW
    Semin Cutan Med Surg; 2001 Jun; 20(2):109-20. PubMed ID: 11474743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Letter: regression of relapsing dyshidrotic eczema after treatment of concomitant hyperhidrosis with botulinum toxin-A.
    Kontochristopoulos G; Gregoriou S; Agiasofitou E; Nikolakis G; Rigopoulos D; Katsambas A
    Dermatol Surg; 2007 Oct; 33(10):1289-90. PubMed ID: 17903169
    [No Abstract]   [Full Text] [Related]  

  • 24. Double-blind, placebo-controlled, pilot trial of botulinum toxin A in restless legs syndrome.
    Nahab FB; Peckham EL; Hallett M
    Neurology; 2008 Sep; 71(12):950-1. PubMed ID: 18794499
    [No Abstract]   [Full Text] [Related]  

  • 25. Dysphagia as a complication of botulinum toxin injection to treat drooling.
    Tighe D; Gok G; Moody A; Howlett D
    Br J Oral Maxillofac Surg; 2014 Sep; 52(7):673; discussion 673-4. PubMed ID: 24845119
    [No Abstract]   [Full Text] [Related]  

  • 26. Adverse events following botulinum toxin type A treatment in children with cerebral palsy.
    Langdon K; Blair E; Davidson SA; Valentine J
    Dev Med Child Neurol; 2010 Oct; 52(10):972-3; author reply 974. PubMed ID: 20561011
    [No Abstract]   [Full Text] [Related]  

  • 27. Delayed Antitoxin Treatment of Two Adult Patients with Botulism after Cosmetic Injection of Botulinum Type A Toxin.
    Fan KL; Wang YL; Chu G; Leung LP
    J Emerg Med; 2016 Dec; 51(6):677-679. PubMed ID: 27687174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Botulinum toxin treatment in children].
    Sätilä H; Vähäsarja V; Paavilainen P
    Duodecim; 2011; 127(22):2417-24. PubMed ID: 22238919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysport produces intrinsically more swallowing problems than Botox: unexpected results from a conversion factor study in cervical dystonia.
    Dressler D
    J Neurol Neurosurg Psychiatry; 2002 Nov; 73(5):604; author reply 604. PubMed ID: 12397170
    [No Abstract]   [Full Text] [Related]  

  • 30. Palmar hyperhidrosis in a 13-year-old boy: treatment with botulinum toxin A.
    Vázquez-López ME; Pego-Reigosa R
    Clin Pediatr (Phila); 2005; 44(6):549-51. PubMed ID: 16015405
    [No Abstract]   [Full Text] [Related]  

  • 31. Axillary injection of botulinum A toxin in a patient with muscle cramps associated with severe axillary hyperhidrosis.
    Filosto M; Bertolasi L; Fincati E; Priori A; Tomelleri G; Chieregato G; Rizzuto N
    Acta Neurol Belg; 2001 Jun; 101(2):121-3. PubMed ID: 11486559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse events with botulinum toxin treatment in cervical dystonia: How much should we blame placebo?
    Duarte GS; Rodrigues FB; Ferreira JJ; Costa J
    Parkinsonism Relat Disord; 2018 Nov; 56():16-19. PubMed ID: 29910156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy, side effects and patient satisfaction with wrist conduction block anaesthesia prior to the treatment of palmar hyperhidrosis with botulinum toxin type A].
    Siebert T; Sinkgraven R; Fuchslocher M; Rzany B
    J Dtsch Dermatol Ges; 2003 Nov; 1(11):876-83. PubMed ID: 16281578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treating childhood hyperhidrosis with botulinum toxin type A.
    Bhakta BB; Roussounnis SH
    Arch Dis Child; 2002 Jan; 86(1):68. PubMed ID: 11806899
    [No Abstract]   [Full Text] [Related]  

  • 35. Commentary: Botulinum toxin in clinical medicine: part II.
    Benedetto AV
    Clin Dermatol; 2004; 22(1):1-2. PubMed ID: 15158537
    [No Abstract]   [Full Text] [Related]  

  • 36. Botulinum toxin for urogenital conditions.
    Eccleston KJ; Woolley PD
    Int J STD AIDS; 2008 Dec; 19(12):797-9. PubMed ID: 19050206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin (Botox, Dysport, and Myobloc): pharmacology 101.
    Wynn RL
    Gen Dent; 2011; 59(2):88-90. PubMed ID: 21903516
    [No Abstract]   [Full Text] [Related]  

  • 38. Botulinum toxin A for focal hyperhidrosis in leg amputees: a case report.
    Wollina U; Konrad H; Graefe T; Thiele J
    Acta Derm Venereol; 2000 May; 80(3):226-7. PubMed ID: 10954228
    [No Abstract]   [Full Text] [Related]  

  • 39. Botulinum Toxin A in bruxers. One year experience.
    Redaelli A
    Saudi Med J; 2011 Feb; 32(2):156-8. PubMed ID: 21301762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin for chronic migraine.
    Med Lett Drugs Ther; 2011 Jan; 53(1356):7-8. PubMed ID: 21252842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.